Brief: Aegirbio Signs Agreement For Sale Of COVID-19 Tests In Germany
May 4 (Reuters) - Aegirbio AB AEGIR.ST :
* SIGNS AGREEMENT FOR SALE OF COVID-19 TESTS IN GERMANY
Source text for Eikon: ID:nWkr3LTjDz
Further company coverage: AEGIR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Subgen AI AB
See all newsBrief: Spanish Government Authorizes €19.2 Mln Investment In Subgen AI Unit
Brief: Subgen AI To Appeal Court Verdict Upholding SEK 12 Mln Regulatory Fine
Brief: Subgen AI Announces Outcome Of Directed Issue Of Shares
Brief: Subgen AI Plans Share Issue, Eyes 58.8% Substrate AI Stake
Brief: Subgen AI Says Administrative Court Upholds Fine On Magnasense